<p>Millions of people are now successfully using hormone antagonists for the treatment of endocrine-dependent cancers. In Hormone Therapy in Breast and Prostate Cancer, many of today's leading researchers and clinicians describe the principles underlying these targeted treatments, assess the actions
Hormone Therapy in Breast and Prostate Cancer
β Scribed by V. Craig Jordan, Barrington J.A. Furr (auth.), V. Craig Jordan, Barrington J.A. Furr (eds.)
- Publisher
- Humana Press
- Year
- 2002
- Tongue
- English
- Leaves
- 421
- Series
- Cancer Drug Discovery and Development
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
Millions of people are now successfully using hormone antagonists for the treatment of endocrine-dependent cancers. In Hormone Therapy in Breast and Prostate Cancer, many of today's leading researchers and clinicians describe the principles underlying these targeted treatments, assess the actions of new and established agents, and illustrate the new applications of hormonal chemoprevention for breast cancer. Topics range from preclinical and clinical antiestrogens to the inhibition of estrogen synthesis and the effects of androgen withdrawal. A wide variety of proven and new agents are discussed-antiestrogens, including aromatase inhibitors (anastrozole, letrozole, and others), SERMs (tamoxifen, raloxifene, and others), and such antiandrogenic strategies as goserelin and bicalutamide.
Unique in its synthesis, Hormone Therapy in Breast and Prostate Cancer offers medical and surgical oncologists, urologists, physicians, and clinical pharmacologists a sound basis for understanding targeted treatments of breast and prostate cancers, and provides a well-proven model for developing powerful new cancer therapeutics.
β¦ Table of Contents
Front Matter....Pages I-XVI
Front Matter....Pages 1-1
An Introduction to the Regulation of Sex Steroids for the Treatment of Cancer....Pages 1-13
Front Matter....Pages 15-15
Antiestrogens and the Cell Cycle....Pages 17-45
Drug Resistance to Antiestrogens....Pages 47-68
Mechanisms of Liver Carcinogenesis by Antiestrogens....Pages 69-81
The Effects of Triphenylethylene Antiestrogens on Parameters of Multistage Hepatocarcinogenesis in the Rat....Pages 83-131
Preclinical Studies of Raloxifene and Related Compounds....Pages 133-159
Pure Antiestrogens....Pages 161-181
Front Matter....Pages 183-183
Tamoxifen for the Treatment of Breast Cancer....Pages 185-193
Clinical Utility of New Antiestrogens....Pages 195-212
Breast-Cancer Prevention with Antiestrogens....Pages 213-231
Front Matter....Pages 233-233
Aromatase Inhibitors....Pages 235-263
Clinical Utility of Aromatase Inhibitors....Pages 265-291
LH-RH Agonists for the Treatment of Breast Cancer....Pages 293-308
Front Matter....Pages 309-309
Molecular Action of Androgens....Pages 311-324
Steroidal Antiandrogens....Pages 325-346
Nonsteroidal Antiandrogens....Pages 347-368
LH-RH Agonist Role in Prostate Cancer Management....Pages 369-382
Front Matter....Pages 383-383
Recent Progress in Breast Cancer Research....Pages 385-408
Back Matter....Pages 409-420
β¦ Subjects
Oncology; Cancer Research; Pharmacology/Toxicology
π SIMILAR VOLUMES
Northwestern Univ., Chicago, IL. Presents a review of the endocrine treatment of breast and prostate cancer by the originators, a model for making new discoveries in the chemoprevention of cancer, a synthesis of history and clinical practice, and a guide for progress. DNLM: Breast Neoplasms--drug th
<p>It has been recognized for many years that cancers originating in the breast and prostate gland are frequently 'endocrine-dependent. ' Traditional theraΒ pies included surgical endocrine ablative procedures or pharmacologic horΒ mone administration, both designed to antagonize the stimulatory eff
<p><p>This comprehensive reference expounds the current state of hormone therapy and castration resistance of prostate cancer (PCa). Previously, the incidence of PCa in Asian countries was relatively low, but it has been increasing dramatically in recent years. Although most of the new cases are dia
This book comprehensively reviews the potential of focal therapy and discusses why the changing face of prostate cancer warrants a change in the way we treat men with the disease. It deals with the mechanisms by which disease can be localized within the gland and then the different technologies used